Brief: RenovoRx Q2 Net Income USD -2.911 Million
12/08/2026 21:06
BRIEF-RenovoRx Q2 Net Income USD -2.911 Million Aug 12 (Reuters) - RenovoRx Q2 operating expenses USD 4.115 million.
- Q2 basic EPS USD -0.06
- Q2 EPS USD -0.06
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer